Skip to main content

Herb-drug interactions

Guest Editors:
Awodayo O. Adepiti, PhD, Obafemi Awolowo University, Nigeria
Swapnil P. Borse, PhD, Savitribai Phule Pune University, India
Márcio Rodrigues, PhD, University of Beira Interior, Portugal
Cheng-Peng Sun, PhD Tianjin University of Traditional Chinese Medicine, China


BMC Complementary Medicine and Therapies called for submissions to our Collection on Herb-drug interactions. This collection welcomes studies that look at the pharmacological, physiological and biochemical aspects of herb-drug interactions. We also welcomed observational studies that look at prevalence, patterns of use, and risk factors associated with the concurrent use of herbal drugs with conventional medicine. Studies that look at translatability of herb-drug interactions reported in in vitro and in vivo research, and studies that utilize real world data that may serve as a tool in improving decision making in clinical settings were also welcomed. 

Meet the Guest Editors

Back to top

Awodayo O. Adepiti: Obafemi Awolowo University, Nigeria

Awodayo O. Adepiti is a Senior Lecturer in the Department of Pharmacognosy, Obafemi Awolowo University, Ile-Ife, Nigeria. Her research focus includes verification of traditional antimalarial claims of plants, assessment of herb-drug interactions in murine models and humans.  She has served as the National Secretary (2007 - 2016) of the Nigerian Society of Pharmacognosy, a Society that promotes the education and use of medicinal plants.  She is a co-grantee in two patents, has one book chapter and is the Principal Investigator in an on-going project on Nigerian antimalarial plants.
 

Swapnil P. Borse: Savitribai Phule Pune University, India

Swapnil P. Borse is a consultant at the AYUSH Center of Excellence in the Department of Health Sciences, Savitribai Phule Pune University. He specializes in the area of drug Interaction, herb-drug-disease interaction, drug metabolism and pharmacokinetics, integrative PK-PD modelling, development of clinically simulated novel translational animal models and clinical trials focusing on Ayurveda-based fundamental and integrative research. He has published 22 articles, 2 book chapters, and holds 2 patents.
 

Márcio Rodrigues: University of Beira Interior, Portugal

Márcio Rodrigues is Adjunct Professor at the Institute Polytechnic of Guarda, Portugal, and is Invited Assistant Professor at the Faculty of Health Sciences of the University of Beira Interior, Portugal. His research interests include the development and application of in vitro and in vivo assays in rodents to evaluate the pharmacokinetic and the pharmaco-toxicological properties of drugs. These kinds of studies are used mainly to support the assessment of potential drug-drug or herb-drug interactions and development of novel drug formulations. He has published 51 articles, 3 book chapters and participated as investigator in 4 projects.
 

Cheng-Peng Sun: Tianjin University of Traditional Chinese Medicine, China

Prof Cheng-Peng Sun currently works at Tianjin University of Traditional Chinese Medicine. His major research interests include chemical biology, inflammatory immunity, pharmacodyamic substances of traditional Chinese medicines, and natural modulators of sEH. To date, he has published more than 70 papers on journals indexed by the Science Citation Index, such as PNAS, ACS Cent Sci, JHM, APSB, and IJBS, as the first or corresponding author.
 

About the Collection

BMC Complementary Medicine and Therapies is calling for submissions to our Collection on Herb-drug interactions. 

This collection welcomes studies that look at the pharmacological, physiological and biochemical aspects of herb-drug interactions. We also welcome observational studies that look at prevalence, patterns of use, and risk factors associated with the concurrent use of herbal drugs with conventional medicine. Studies that look at translatability of herb-drug interactions reported in in vitro and in vivo research, and studies that utilize real world data that may serve as a tool in improving decision making in clinical settings are particularly welcomed. 

With the increasing popularity of the use of herbal medicine, the field of herb-drug interactions is rapidly evolving and has gained significant attention. With the concurrent use of herbal drugs alongside with conventional medication, further research into adverse events, safety concerns, changes in drug efficacy due to herb-drug interactions are crucial.

By bridging the gap between complementary medicine and conventional therapies, this collection launched in BMC Complementary Medicine and Therapies seeks to enhance our understanding, and encourage evidence building on herb-drug interactions, with the ultimate goal of advancing patient care. 


Image credit: Artfully79 / Getty Images / iStock

  1. Oral squamous cell carcinoma (OSCC) ranks as the sixth most common malignancy globally. Cisplatin is the standard chemotherapy for OSCC, but resistance often reduces its efficacy, necessitating new treatments ...

    Authors: Amany E. Ragab, Ghada M. Al-Ashmawy, Sherin R. El Afify, Ola A. El-Feky and Amera O. Ibrahim
    Citation: BMC Complementary Medicine and Therapies 2025 25:25
    Content type: Research Published on:

  2. The treatment of advanced colorectal cancer (CRC) has progressed slowly, with chemotherapy combined with targeted therapy being the first-line treatment for the disease, but the improvement in efficacy is not ...

    Authors: Jingyuan Wu, Yuansha Ge, Guanghui Zhu, Ruike Gao, Xiaoyu Zhu, Ying Zhang and Jie Li
    Citation: BMC Complementary Medicine and Therapies 2024 24:429
    Content type: Study Protocol Published on:

  3. While more and more people tend to use herbal products thinking they are safer than conventional western medicine, the reality is other. If natural products are bio-active and possess potential therapeutic act...

    Authors: Anthony Cnudde, Camille Allely, Natacha Biset, Pierre Champy, Nathalie Fouilhé, Fanny Huret, Sibi Lawson, Aline Mercan, Doris Pascale Noukela Noumi, Serge Michalet, Andrea Montis, Stephanie Pochet, Audrey Schils, Cecilia Tangeten, Michel Tod, Pierre Van Antwerpen…
    Citation: BMC Complementary Medicine and Therapies 2024 24:414
    Content type: Research Published on:

  4. Nano-drug delivery systems have become a promising approach to overcoming problems such as low solubility and cellular uptake of drugs. Along with various delivery devices, dendrimers are widely used through t...

    Authors: Saeideh Ebrahimi, Majid Sadeghizadeh, Mohammad Reza Aghasadeghi, Mehdi Shafiee Ardestani, Shaghayegh Adib Amini and Roohollah Vahabpour
    Citation: BMC Complementary Medicine and Therapies 2024 24:350
    Content type: Research Published on:

  5. The growing global threat of antimicrobial resistance endangers both human and animal life, necessitating the urgent discovery of novel antimicrobial solutions. Medicinal plants hold promise as sources of pote...

    Authors: Anees Ur Rahman, Abdullah Abdullah, Shah Faisal, Basem Mansour and Galal Yahya
    Citation: BMC Complementary Medicine and Therapies 2024 24:266
    Content type: Research Published on:

  6. Cepharanthin® alone or in combination with glucocorticoid (GC) has been used to treat chronic immune thrombocytopenia (ITP) since the 1990s. Cepharanthine (CEP) is one of the main active components of Cepharanthi...

    Authors: Wencheng Xu, Shuhe Chen, Xiaoqin Wang, Jinwen Min, Sachiko Tanaka, Kenji Onda, Kentaro Sugiyama, Haruki Yamada and Toshihiko Hirano
    Citation: BMC Complementary Medicine and Therapies 2024 24:186
    Content type: Research Published on:

Submission Guidelines

Back to top

This Collection welcomes submission of original Research Articles. Should you wish to submit a different article type, please read our submission guidelines to confirm that type is accepted by the journal. Articles for this Collection should be submitted via our submission system, Snapp. During the submission process you will be asked whether you are submitting to a Collection, please select "Herb-drug interactions" from the dropdown menu.

Articles will undergo the journal’s standard peer-review process and are subject to all of the journal’s standard policies. Articles will be added to the Collection as they are published.

The Editors have no competing interests with the submissions which they handle through the peer review process. The peer review of any submissions for which the Editors have competing interests is handled by another Editorial Board Member who has no competing interests.